Population screening for fragile X
- PMID: 1349946
- DOI: 10.1016/0140-6736(92)91142-u
Population screening for fragile X
Abstract
A screening programme to detect fragile X syndrome has been operating in New South Wales, Australia, since 1984. The aim of this programme is to find previously unidentified individuals with the syndrome so that their extended families can be properly informed of the risks before making decisions about childbearing. 14,225 individuals attending adult and child facilities for the intellectually handicapped have been screened, of whom 8172 have been offered testing for the fragile X syndrome with a 79% uptake of the service. 253 probands were found, and in the extended families 818 females at 25-100% risk of being carriers were interviewed and counselled. Continuing contact was maintained and prenatal diagnosis was offered. The effect of the programme was assessed in a subgroup of 90 individuals, most of whom were appreciative of the service and felt that they had been adequately informed. The influence of knowing the diagnosis and its genetic implications were also assessed, the main consequences being a 26% reduction in births and a 61% uptake of prenatal diagnosis. Improved techniques for diagnosis of fragile X have benefited the families identified and counselled, suggesting that systematic screening for fragile X should be an essential component of community genetic services.
Similar articles
-
Fragile X screening program in a Spanish region.Am J Med Genet. 1992 Apr 15-May 1;43(1-2):333-8. doi: 10.1002/ajmg.1320430151. Am J Med Genet. 1992. PMID: 1605207
-
New York State screening program for fragile X syndrome: a progress report.Am J Med Genet. 1992 Apr 15-May 1;43(1-2):328-32. doi: 10.1002/ajmg.1320430150. Am J Med Genet. 1992. PMID: 1605206
-
Preventive screening for the fragile X syndrome.N Engl J Med. 1986 Sep 4;315(10):607-9. doi: 10.1056/NEJM198609043151002. N Engl J Med. 1986. PMID: 3736599
-
Screening for fragile X syndrome: information needs for health planners.J Med Screen. 1997;4(2):60-94. doi: 10.1177/096914139700400204. J Med Screen. 1997. PMID: 9275266 Review. No abstract available.
-
Screening for fragile X syndrome.Health Technol Assess. 1997;1(4):i-iv, 1-71. Health Technol Assess. 1997. PMID: 9414543 Review.
Cited by
-
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.Am J Hum Genet. 1997 Sep;61(3):660-7. doi: 10.1086/515496. Am J Hum Genet. 1997. PMID: 9326332 Free PMC article.
-
Pre-conception and antenatal screening for the fragile site on the X-chromosome.Cochrane Database Syst Rev. 2002;2003(1):CD001806. doi: 10.1002/14651858.CD001806. Cochrane Database Syst Rev. 2002. PMID: 11869607 Free PMC article.
-
The impact of FMR1 gene mutations on human reproduction and development: a systematic review.J Assist Reprod Genet. 2016 Sep;33(9):1135-47. doi: 10.1007/s10815-016-0765-6. Epub 2016 Jul 18. J Assist Reprod Genet. 2016. PMID: 27432256 Free PMC article.
-
Fragile X syndrome.Indian J Pediatr. 1998 Jul-Aug;65(4):513-8. doi: 10.1007/BF02730883. Indian J Pediatr. 1998. PMID: 10773898 Review.
-
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.Psychopharmacology (Berl). 2014 Mar;231(6):1217-26. doi: 10.1007/s00213-013-3330-3. Psychopharmacology (Berl). 2014. PMID: 24232444 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical